Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Julia Blau"'
Autor:
Bernard Kaić, B. Mounaud, Andrew Clark, Céline Hoestlandt, V. Višekruna Vučina, V. Stamenić, N. Kožnjak, S. Kurečić Filipović, Julia Blau
Publikováno v:
Vaccine. 33:A209-A218
Objective Pneumococcus is a known cause of meningitis, pneumonia, sepsis, and acute otitis media in children and adults globally. Two new vaccines for children have the potential to prevent illness, disability, and death, but these vaccines are expen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::598b8fcd24351d9305d322fe3e022b43
https://doi.org/10.1016/j.vaccine.2014.12.043
https://doi.org/10.1016/j.vaccine.2014.12.043
Autor:
Andrew Clark, M. Shakhnazarova, R. Chlikadze, Céline Hoestlandt, M. Kherkheulidze, K. Goginashvili, T. Dolakidze, T. Komakhidze, N. Kopaleishvili, Julia Blau
Publikováno v:
Vaccine. 33:A219-A226
Objective Financial support from the Global Alliance for Vaccines and Immunization (GAVI) to introduce the 10-valent pneumococcal conjugate vaccine (PCV10) into the routine childhood immunization schedule in Georgia is ending in 2015. As a result, th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8eae02a62b9fe8be67d624d53c38cbf6
https://doi.org/10.1016/j.vaccine.2014.12.070
https://doi.org/10.1016/j.vaccine.2014.12.070
Autor:
Céline Hoestlandt, Andrew Clark, L Baxter, Julia Blau, Liudmila Mosina, Bérénice Mounaud, Ana Gabriela Felix Garcia
Publikováno v:
Vaccine. 33:A34-A39
Background For many years, low- and middle-income countries have made efforts to strengthen national decision-making on immunization. The Pan American Health Organization (PAHO) ProVac Initiative was established to help expedite the use of evidence-b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32bdcafa9c83fa000a669aaa8c4a0d9e
https://doi.org/10.1016/j.vaccine.2014.12.073
https://doi.org/10.1016/j.vaccine.2014.12.073
Autor:
Philippe Duclos, Marine Clementz, Barbara Jauregui, Julia Blau, Kamel Senouci, Nihal Abeysinghe, Yoshihiro Takashima, Cara Bess Janusz, Richard Mihigo, Nahad Sadr-Azodi, Niyazi Cakmak, Liudmila Mosina
Publikováno v:
Vaccine. 31:2653-2657
A National Immunization Technical Advisory Group (NITAG) is an expert advisory committee that provides evidence-based recommendations to the Ministry of Health (MoH) to guide immunization programs and policies. The World Health Organization (WHO), th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b2c45b70bcddccd41779acf594871c8
https://doi.org/10.1016/j.vaccine.2013.01.047
https://doi.org/10.1016/j.vaccine.2013.01.047
Autor:
Brad D. Gessner, Philippe Stoeckel, John D. Clemens, Julia Blau, Papa Coumba Faye, Alfred Da Silva, Kamel Senouci, Batmunkh Nyambat, Lara Gautier, Michael O. Favorov
Publikováno v:
Vaccine. 28:A26-A30
Multiple health priorities, limited human resources and logistical capacities, as well as expensive vaccines with limited funds available increase the need for evidence-based decision making in immunization programs. The aim of the Supporting Indepen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2fe575137c15ff515f438ef783f193a
https://doi.org/10.1016/j.vaccine.2010.02.028
https://doi.org/10.1016/j.vaccine.2010.02.028
Autor:
L Baxter, Raymond Hutubessy, Cara Bess Janusz, Aline Munier, Rana A. Hajjeh, Jon Kim Andrus, Deborah Atherly, Ana Gabriela Felix Garcia, Benjamin A. Lopman, Barbara Jauregui, Mercy Mvundura, Andrew Clark, Ciro de Quadros, Julia Blau
Publikováno v:
Jauregui, B, Felix Garcia, A G, Bess Janusz, C, Blau, J, Munier, A, Atherly, D, Mvundura, M, Hajjeh, R, Lopman, B, Clark, A D, Baxter, L, Hutubessy, R, de Quadros, C & Andrus, J K 2015, ' Evidence-based decision-making for vaccine introductions : overview of the ProVac International Working Group's experience ', Vaccine, vol. 33, no. Supplement 1, pp. A28-A33 . https://doi.org/10.1016/j.vaccine.2014.10.090
Introduction: Pan American Health Organization's (PAHO) ProVac Initiative aims to strengthen countries' technical capacity to make evidence-based immunization policy. With financial support from the Bill and Melinda Gates Foundation, PAHO established
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c987e1660ac0fcfdda89d59412fbc226
https://researchportal.port.ac.uk/portal/en/publications/evidencebased-decisionmaking-for-vaccine-introductions(280add77-4cc5-4678-b616-8f34c58dcf0a).html
https://researchportal.port.ac.uk/portal/en/publications/evidencebased-decisionmaking-for-vaccine-introductions(280add77-4cc5-4678-b616-8f34c58dcf0a).html
Autor:
Andrew Clark, Erida Nelaj, Julia Blau, Ana Gabriela Felix Garcia, Carlos Lara, Silvia Bino, Céline Hoestlandt, Albana Ahmeti, Iria Preza, Artan Simaku
Publikováno v:
Vaccine. 33
Background Rotavirus vaccines have been introduced in several European countries but can represent a considerable cost, particularly for countries that do not qualify for any external financial support. This study aimed to evaluate the cost-effective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c55e4740dbcc3ab2d5904a8421932ce7
https://pubmed.ncbi.nlm.nih.gov/25919162
https://pubmed.ncbi.nlm.nih.gov/25919162
Autor:
Alfred Douba, Bradford D. Gessner, Papa Coumba Faye, Kamel Senouci, Simplice N’Cho Dagnan, Jeanine Tagliante Saracino, Julia Blau
Publikováno v:
Vaccine. 30(15)
In January 2010, Cote d’Ivoire became the first GAVI-eligible country in sub-Saharan Africa to establish a National Immunization Technical Advisory Group (NITAG). The Cote d’Ivoire “National Committee of Independent Experts for Vaccination and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9ab4dda60ea77ab5077428d379b190c
https://pubmed.ncbi.nlm.nih.gov/22330125
https://pubmed.ncbi.nlm.nih.gov/22330125
Autor:
Bradford D. Gessner, Nyambat Batmunkh, Julia Blau, Papa Coumba Faye, Kamel Senouci, Nguyen Tran Hien, Don Douglas, Mireille Dosso, Alfred Da Silva
Publikováno v:
BMC Proceedings, Vol 5, Iss Suppl 1, p P105 (2011)
BMC Proceedings
BMC Proceedings
In both developed and developing countries, the need for evidence-based decision-making in immunization programs has become crucial in light of multiple health priorities, limited human resources and logistical capacities, as well as the high cost of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0196ec8776d7c289ada612acffddee45
https://doi.org/10.1186/1753-6561-5-s1-p105
https://doi.org/10.1186/1753-6561-5-s1-p105
Autor:
Julia Blau, Kelly Ernst, Matthias Wismar, Franz Baro, Mojca Gabrijelcic-Blenkus, Konrade von Bremen, Reiner Fehr, Gabriel Gulis, Tapani Kauppinen, Odile Mekel, Kirsi Nelimarkka, Kerttu Perttila, Nina Scagnetti, Martin Sprenger, Rudolf Welteke, Ingrid Stegeman
Publikováno v:
Blau, J, Ernst, K, Wismar, M, Baro, F, Gabrijelcic-Blenkus, M, von Bremen, K, Fehr, R, Gulis, G, Kauppinen, T, Mekel, O, Nelimarkka, K, Perttila, K, Scagnetti, N, Sprenger, M, Welteke, R & Stegeman, I 2007, The use of HIA across Europe . in M Wismar, J Blau, K Ernst & J Figueras (eds), The effectiveness of health impact assessment : Scope and limitations of supporting decision making in Europe . World Health Organization, Copenhagen, pp. 37-55 .
University of Southern Denmark
University of Southern Denmark
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::bb825a9b16034c1156044c5a1ab99f45
https://portal.findresearcher.sdu.dk/da/publications/57274d80-fca1-11dc-86ef-000ea68e967b
https://portal.findresearcher.sdu.dk/da/publications/57274d80-fca1-11dc-86ef-000ea68e967b